赛马鲁肽
医学
2型糖尿病
内科学
胰高血糖素样肽-1
兴奋剂
糖尿病
胰高血糖素样肽1受体
内分泌学
利拉鲁肽
受体
作者
Juan P. Frías,Melanie J. Davies,Julio Rosenstock,Federico C. Pérez Manghi,Laura Fernández Landó,Brandon K. Bergman,Bing Liu,Xuewei Cui,Katelyn Brown
标识
DOI：10.1056/nejmoa2107519
摘要
In patients with type 2 diabetes, tirzepatide was noninferior and superior to semaglutide with respect to the mean change in the glycated hemoglobin level from baseline to 40 weeks. (Funded by Eli Lilly; SURPASS-2 ClinicalTrials.gov number, NCT03987919.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
热心市民小杨
null
Lemon
无极微光
L_BD
YifanWang
Arthur
乐空思
cz
干净的琦
医学小渣渣
tuanheqi
大力的灵雁
阿志
MchemG
Auston_zhong
GingerF
Twonej
andrele
maox1aoxin
皖公网安备34019202002308
